Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Vericel (VCEL) over the last 14 years, with Q3 2025 value amounting to $100.4 million.

  • Vericel's Cash & Equivalents rose 8703.64% to $100.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.4 million, marking a year-over-year increase of 8703.64%. This contributed to the annual value of $74.5 million for FY2024, which is 786.24% up from last year.
  • Per Vericel's latest filing, its Cash & Equivalents stood at $100.4 million for Q3 2025, which was up 8703.64% from $80.5 million recorded in Q2 2025.
  • Vericel's 5-year Cash & Equivalents high stood at $100.4 million for Q3 2025, and its period low was $43.0 million during Q2 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $60.5 million (2023), whereas its average is $62.7 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 10324.21% in 2021, then plummeted by 2526.42% in 2022.
  • Over the past 5 years, Vericel's Cash & Equivalents (Quarter) stood at $68.3 million in 2021, then dropped by 25.26% to $51.1 million in 2022, then skyrocketed by 35.29% to $69.1 million in 2023, then rose by 7.86% to $74.5 million in 2024, then surged by 34.73% to $100.4 million in 2025.
  • Its Cash & Equivalents stands at $100.4 million for Q3 2025, versus $80.5 million for Q2 2025 and $73.5 million for Q1 2025.